
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
[ Tue, Jan 24th 2023 ]: WOPRAI
Matthew Harrison Maintained (BOLT) at Hold with Decreased Target to $3 on, Jan 24th, 2023


🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "Bolt Biotherapeutics, Inc." (BOLT) at Hold with Decreased Target from $5 to $3 on, Jan 24th, 2023.
Matthew has made no other calls on BOLT in the last 4 months.
There is 1 other peer that has a rating on BOLT. Out of the 1 peers that are also analyzing BOLT, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Edward White of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $8 on, Tuesday, October 4th, 2022